Context: Insufficient efficacy and safety data for off-label use of aromatase inhibitors to augment height in boys with short stature.
Objective: To compare anastrozole and letrozole in treatment of idiopathic short stature in pubertal boys.
Design: Open-label trial with 2 treatment arms.